| Aug 12 |
Cytosorbents Q2 2024 Earnings Preview
|
| Aug 1 |
CytoSorbents regains compliance with Nasdaq
|
| Aug 1 |
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
|
| Jul 17 |
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
|
| Jul 2 |
CytoSorbents gets new $20M credit facility
|
| Jul 2 |
CytoSorbents Secures $20 Million Credit Facility
|
| Jun 24 |
CytoSorbents reports regulatory approval of CytoSorb in Taiwan
|
| Jun 24 |
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
|
| Jun 13 |
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
|
| Jun 4 |
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
|
